Practice Areas
Life Sciences, PatentsIndustry & Technical Focus
Biotechnology, Pharmaceuticals, Microbiology, Immunology, Biochemistry
Practice Description
Dr. Williams's practice focuses on patent prosecution and opinion work in the biotechnology area. She has over 13 years of experience working with clients to develop strategies for effective patent coverage, including patent prosecution, opinion work, freedom to operate analyses, and monitoring activities of competitors.
Megan represents a diverse group of clients, from small biotechnology companies, to institutions, and large corporations. She also works with companies and investors to provide due diligence evaluations and opinions in connection with collaborations, acquisitions, licensing, and financing.
Notable Experience
- Assisting clients with U.S. and foreign patent preparation, prosecution, freedom to operate, and opinion work.
- Developing patent portfolios for a major university to assist in the marketing of intellectual property to potential investors.
- Advising a major pharmaceutical company on the strengths of intellectual property assets held by companies it was acquiring.
- Representative patents: US 7,736,647 Anti-CD71 monoclonal antibodies and uses thereof for treating malignant tumor cells
US 7,700,097 Purification and preferential synthesis of binding molecules
US 7,678,371 Methods of humanizing immunoglobulin variable regions through rational modification of complementarity determining residues
US 7,531,174 Cripto blocking antibodies and uses thereof
US 7,468,269 Reagents for recombinogenic engineering and uses thereof
US 7,427,403 Methods for inhibiting lymphotoxin β receptor signalling
US 7,423,138 Compositions and methods for treating papillomavirus-infected cells
US 7,405,342 Transgenic mice expressing heterologous complement receptor type 1 (CR1) molecules on erythrocytes and uses therefor
US 7,399,846 Libraries of oligomers labeled with different tags
US 7,393,944 T-bet compositions and methods of use thereof
US 6,946,247 RNAse probe protection assays in screening for modulators of immunoglobulin germline transcription
US 6,653,444 Polypeptides comprising a B7 extracellular domain
US 6,319,709 Tumor cells with increased immunogenicity and uses therefor
Prior Experience
Megan has extensive research experience in the immunology field.
- Conducting post-doctoral research in the area of immunology at the National Institutes of Health.
- Conducting research in the area of transplantation immunology and participation in immunoassay development.
Publications & Speaking Engagements
- Co-author, "District Court Invalidates Gene Patents," June 2010.
- Moderator: “The Recent Impact of FDA Regulatory Changes on Biomedical Product Approval and on Company Valuations,” October 1, 2009.
- Author/co-author of 15 scientific research articles and reviews.
